Welcome to LookChem.com Sign In|Join Free

CAS

  • or

141068-94-2

Post Buying Request

141068-94-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

141068-94-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 141068-94-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,1,0,6 and 8 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 141068-94:
(8*1)+(7*4)+(6*1)+(5*0)+(4*6)+(3*8)+(2*9)+(1*4)=112
112 % 10 = 2
So 141068-94-2 is a valid CAS Registry Number.

141068-94-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-amino-5-methyl-3-oxo-3,4-dihydro-(2H)-1,4-benzoxazine

1.2 Other means of identification

Product number -
Other names 6-Amino-5-methyl-4H-benzo[1,4]oxazin-3-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:141068-94-2 SDS

141068-94-2Downstream Products

141068-94-2Relevant articles and documents

Synthesis and evaluation of 2-[(5-methylbenz-1-ox-4-azin-6- yl)imino]imidazoline, a potent, peripherally acting α2 adrenoceptor agonist

Munk, Stephen A.,Harcourt, Dale,Ambrus, Gy?rgy,Denys, Lydia,Gluchowski, Charles,Burke, James A.,Kharlamb, Alexander B.,Manlapaz, Cynthia A.,Padillo, Edwin U.,Runde, Eileen,Williams, Linda,Wheeler, Larry A.,Garst, Michael E.

, p. 3533 - 3538 (1996)

We have synthesized 2-[(5-methylbenz-1-ox-4-azin-6- yl)imino]imidazoline, 3, a potent, peripherally acting α2 adrenoceptor agonist. The agent is conveniently prepared in five steps from 2-amino-m- cresol. The agent has demonstrated good selectivity for α2 adrenoceptors in binding and functional studies. When applied topically to eyes, the agent is efficacious for the reduction of intraocular pressure. The agent does not penetrate the blood-brain barrier and, as a consequence, does not lower blood pressure or induce sedation when administered topically or intravenously. We have determined the pK(a) and log P in water versus both octanol and dodecane of 3 and a set of related agents. The best physical parameter to explain its lack of central nervous system penetration appears to be log P measured in octanol versus water.

Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors

-

, (2008/06/13)

Methods and compounds for the treatment of conditions including pain, particularly chronic pain, glaucoma or elevated intraocular pressure with reduced cardiovascular or sedative side effects. Also included are methods of making and using such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 141068-94-2